DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…
DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…
DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…
DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…
The Medical Device Market is witnessing robust expansion driven by rising healthcare expenditure, growing prevalence of chronic diseases, and accelerating…
Amalgam’s Scalable Digital Platform Powers the Mobile App for Biolinq Shine™, an FDA De Novo–Cleared, Needle-Free Glucose SensorWILMINGTON, Del.--(BUSINESS WIRE)--#clinical--Amalgam…
$750,000 grant will accelerate the development of a point-of-care diagnostic to improve maternal health outcomes in low-resource settings SEATTLE, Oct.…
Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage…
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Wearable Medical Devices Market is poised for remarkable expansion, projected to surge from…
BERKELEY, Calif, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital…